Celltrion | 068270 - Fremdkapital

Aktienkurs
188,800.00
Täglich Wechseln
-6,300.00 -3.23%
Monatlich
-9.67%
Jährlich
22.60%
Q2 Prognose
186,972.16




Fremdkapital Veränderung Datum
Akebia Therapeutics USD 36.39M 11.85M 2026-03
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Celltrion KRW 412.27B 348.97B 2025-12
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
Moderna USD 603M 7M 2026-03
Organon & Co USD 8.55B 75M 2026-03
Revvity USD 2.63B 836K 2026-03
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.41B 67.1M 2026-03
Xeris Pharmaceuticals USD 221.22M 889K 2026-03